Complete Monthly Cost Breakdown: Wegovy vs Mounjaro
Is Wegovy or Mounjaro Better for Predictable Monthly Budgeting?
When evaluating whether Wegovy or Mounjaro is better for your financial planning, Wegovy offers a clear advantage with its predictable monthly cost structure. The 16-week dose escalation follows a defined path: £79.99 for the starter 0.25mg dose, progressing through £94.99 (0.5mg), £99.99 (1mg), and £139.99 (1.7mg) before reaching the maintenance dose of 2.4mg at £209.99 monthly. This transparency allows you to budget accurately from the outset, knowing exactly what each month will cost throughout your treatment journey.
Mounjaro, while effective as a dual GIP and GLP-1 receptor agonist, follows a different pricing and availability structure in the UK market. The key consideration when asking "is Wegovy or Mounjaro better" often comes down to individual response, tolerability, and long-term cost sustainability. Wegovy's established pricing framework, backed by our GPhC-registered pharmacy (#9012878), provides the financial predictability many patients require for successful long-term weight management commitment.
Wegovy vs Mounjaro: Detailed UK Pricing Analysis
The monthly cost comparison reveals distinct advantages for different patient preferences. Wegovy's single-pen pricing ranges from £79.99 to £209.99, with our Getting Started bundles offering convenience - the Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first two months. For patients preferring extended supply security, our Ultimate Stability Trio provides three months of maintenance 2.4mg doses for £649.99, eliminating monthly reordering concerns while maintaining cost predictability.
When considering whether Wegovy or Mounjaro is better from a budgeting perspective, factor in the annual maintenance cost. At the 2.4mg maintenance dose, Wegovy costs approximately £2,519.88 annually (12 × £209.99), with returning customers benefiting from the DOSE25 discount code applied at checkout. Our bundle options provide additional convenience, with the Consistency 2.4mg (×2) bundle at £419.99 offering two months of maintenance supply in a single order, simplifying your monthly medication management routine.
Clinical Evidence: Is Wegovy or Mounjaro Better for Long-Term Value?
Clinical trial data helps inform the value proposition when determining whether Wegovy or Mounjaro is better suited to your treatment goals. In the STEP clinical trials, patients taking Wegovy alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight loss of approximately 15.2% at 2 years, supporting the long-term value of the monthly investment.
Mounjaro's tirzepatide mechanism works as a dual GIP and GLP-1 receptor agonist, compared to Wegovy's single GLP-1 action. Both treatments require ongoing commitment, and weight regain studies show that patients typically regain approximately two-thirds of weight lost within one year of stopping treatment. This underscores the importance of considering long-term monthly costs rather than viewing either treatment as a short-term solution when evaluating whether Wegovy or Mounjaro is better for your circumstances.
How Wegovy Works: Understanding Your Monthly Investment
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone produced in your intestines. This mechanism helps reduce appetite and promotes feelings of satiety after smaller meals, potentially reducing food cravings by working on brain appetite centres. The once-weekly injection using the FlexTouch pen system provides consistent medication levels, supporting appetite regulation throughout each week. Understanding this mechanism helps justify the monthly cost investment, as you're not just purchasing medication but accessing a scientifically-designed appetite regulation system. The gradual dose escalation over 16 weeks allows your body to adapt while minimising side effects, ensuring you receive maximum value from each monthly prescription throughout the adjustment period.
Ordering Process: From Assessment to Monthly Delivery
EverydayMeds streamlines the monthly ordering process through our efficient system designed for ongoing treatment success. Complete our 3-minute online clinical assessment detailing your medical history and weight management goals, with prescriber review typically completed within 3 working days (or 24 hours with express service). Once approved, your Wegovy is dispatched via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements essential for medication efficacy. Monthly reordering becomes straightforward once you're established on treatment, with returning customers using code DOSE25 for continued savings. Our GPhC-registered pharmacy (#9012878) ensures all prescriptions meet UK regulatory standards, providing confidence in your monthly medication supply quality and legal compliance.
Storage and Practical Considerations: Monthly Cost Value
Wegovy offers practical advantages that enhance the value of your monthly investment, particularly regarding storage flexibility. While requiring refrigeration at 2-8°C before first use, Wegovy pens can remain at room temperature below 30°C for up to 6 weeks once removed from the fridge - significantly longer than Mounjaro's 21-day room temperature limit. This flexibility reduces medication waste, protecting your monthly investment if you travel or experience temporary storage challenges. The FlexTouch pen system is pre-filled and disposable, eliminating additional equipment costs. Each pen contains four weekly doses at the prescribed strength, with the dose escalation schedule clearly defined: starting at 0.25mg for weeks 1-4, progressing through each level monthly until reaching the 2.4mg maintenance dose, ensuring you understand exactly what each monthly payment delivers.
Is Wegovy or Mounjaro Better for Budget-Conscious Patients?
Budget considerations often determine whether Wegovy or Mounjaro is better suited to individual financial circumstances. Wegovy's transparent pricing structure eliminates unexpected costs, with our discount codes FIRST40 (new customers) and DOSE25 (returning patients) applied at checkout to reach the advertised prices. This predictability allows effective financial planning, particularly important given that weight management is a long-term commitment requiring sustained monthly investment.
The maintenance phase represents the most significant long-term cost consideration. At £209.99 monthly for 2.4mg Wegovy, annual maintenance costs approximately £2,519.88, but this investment must be weighed against potential health benefits and quality of life improvements. Our bundle options provide additional cost management tools, with the Consistency 2.4mg (×2) at £419.99 offering two-month supply security, reducing ordering frequency and ensuring treatment continuity even during busy periods.
Making Your Decision: Expert Support and Transparent Pricing
Both Wegovy and Mounjaro are available from EverydayMeds, ensuring you receive expert prescriber guidance regardless of which treatment proves more suitable for your circumstances. Our clinical team can help determine whether Wegovy or Mounjaro is better based on your medical history, weight management goals, and budget considerations. The assessment process considers factors including previous medication responses, lifestyle requirements, and long-term financial sustainability to ensure your chosen treatment aligns with realistic expectations. Remember to use code FIRST40 for new customer savings or DOSE25 for returning customer benefits, applied automatically at checkout to reach our competitive pricing. Start your assessment today at https://everydaymeds.co.uk/collections/wegovy and begin your personalised weight management journey with complete cost transparency and ongoing clinical support from our experienced team.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
